One of the challenges in caring for patients with mycosis fungoides, the most common cutaneous T-cell lymphoma (CTCL), is early identification of patients who will develop progressive disease. While TNM staging is prognostic, identification of high-risk patients earlier in their disease remains an unmet clinical need. We hypothesized that the balance between anti-tumor CD8 + T cell and anti-inflammatory FOXP3 + T regulatory cell infiltration in the initial CTCL skin biopsy could be predictive of disease progression. To examine this, a cohort of 33 CTCL patients (9 I, 4 II) with a median follow-up of 78 months were divided into two groups depending on whether they developed progressive disease (n¼13). We studied their skin biopsy specimens by multiplexed tyramide signal amplification based staining for CD4, CD8, FoxP3, PD-1 and DAPI expression, followed by image deconvolution and automated cell analysis. Patients with greater CD8 + T cell infiltration had significantly improved progression-free survival in univariate (HR¼0.6, CI 0.4-0.97, p¼0.04) and multivariate analysis (HR 0.4, CI 0.2-0.7, p¼0.01). When we restricted the analysis to early stage patients, this finding remained significant (HR¼0.6, CI 0.4-0.98, p¼0.04) and did not correlate with malignant clone frequency or age. The number of FoxP3 + regulatory T cells, PD-1 + T cells and total CD4 + T cells were not associated with improved survival. Ratios between these cell types were also examined for potential associations with prognosis. We found that an increased ratio of CD4 + T cells:FoxP3 + T cells was associated with worse PFS (HR 1.02, CI 1.0-1.03, p¼.01) but this result did not remain significant in multivariate analysis (p¼0.7). We are in the process of confirming this finding in a larger cohort. In summary, CD8 + T cell density in the lesional skin of CTCL patients is predictive of disease progression and may be a useful adjunct in risk-stratifying early stage patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.